got COVID; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (got COVID) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066h21a) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure and Anxiety.    On 21-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2021, the patient experienced COVID-19 (got COVID) (seriousness criterion hospitalization). The patient was hospitalized from sometime in December 2021 to 06-Jan-2022 due to COVID-19. The patient was treated with VITAMIN D NOS at an unspecified dose and frequency and OXYGEN at an unspecified dose and frequency. At the time of the report, COVID-19 (got COVID) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient was not known of any allergies. No other vaccines given within 1 month prior to Moderna COVID-19 vaccine. Patient was not on any concomitant regular or prescribed medication and reported no medication at all. Patient did not experience a similar event in the past. It was reported that the symptoms were improved. It was also reported that patient had to be on oxygen 24 hours, received all kinds of medication, went to a lung doctor and few doctors more and also reported that right now had 3 different inhalers, Oxygen when needed, CPAP machine which patient had problems to get adjusted with, blood pressure medication, sleep medication, anxiety medication, nasal spray, took cold medication.  The patient was hard to stop coughing and had problems with yellow mucus and congestion.  Company Comment:  This spontaneous case concerns a 57-year-old female patient with no reported medical history, who experienced the unexpected, serious adverse event of special interest COVID-19 on an unknown date after receiving the first dose of mRNA-1273 vaccine that led to hospitalization. Latency between vaccine and event cannot be established. Patient experienced COVID-19 on the same month of vaccination.  Patient presented with cough, yellow mucus, and congestion. She was treated with Vitamin D, nasal spray, inhalers, and unspecified medications for blood pressure, sleep, and anxiety. Management also included oxygen support and continuous positive airway pressure CPAP.  SARS-CoV-2 test was not reported. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a 57-year-old female patient with no reported medical history, who experienced the unexpected, serious adverse event of special interest COVID-19 on an unknown date after receiving the first dose of mRNA-1273 vaccine that led to hospitalization. Latency between vaccine and event cannot be established. Patient experienced COVID-19 on the same month of vaccination.  Patient presented with cough, yellow mucus, and congestion. She was treated with Vitamin D, nasal spray, inhalers, and unspecified medications for blood pressure, sleep, and anxiety. Management also included oxygen support and continuous positive airway pressure CPAP.  SARS-CoV-2 test was not reported. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.